The proposed study is a placebo-controlled, add-on, randomized trial using parallel group designs. This is a close-label and adaptive, multi-centered design with 1:1:1:1 allocation ratio and superiority framework.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Positive PCR with mild to moderate disease
You may not be if
Allergic to iodine
Any co-morbidity other than hypertension and dietetics
